Where it is registered
Each register with its number of medicines and a few of them.
Spain
AEMPS · 2 medicines
- Lynozyfic 200 MG Concentrado Para Solucion Para Perfusion200 mg · concentrado para solución para perfusión · Regeneron Ireland Designated Activity Company
- Lynozyfic 5 MG Concentrado Para Solucion Para Perfusion5 mg · concentrado para solución para perfusión · Regeneron Ireland Designated Activity Company
Netherlands
CBG-MEB · 2 medicines
United States
FDA · 2 medicines
European Union
EMA · 1 medicine
Croatia
HALMED · 1 medicine
All medicines with Linvoseltamab
Every register, a page at a time. Strengths and packs are on each medicine’s page.
1 result
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Lynozyfic | European Union | Authorised | Regeneron Ireland Designated Activity Company (DAC) |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, CBG-MEB, EMA, FDA and HALMED. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 6
- Medicines
- 9
- Companies
- 3